骨骼及关节保健品市场－全球产业规模、份额、趋势、机会及预测（依产品、配方、消费群组、销售管道、地区及竞争格局划分，2021-2031年）

全球骨骼和关节健康补充剂市场预计将从 2025 年的 31.6 亿美元增长到 2031 年的 44.5 亿美元，复合年增长率为 5.87%。

这些营养补充品通常含有钙、维生素D、葡萄糖胺、软骨素和胶原蛋白等成分，旨在维持骨骼完整性并支持关节功能。该市场的成长主要受全球人口老化（老年人更容易出现肌肉骨骼问题）以及越来越多的年轻消费者采取预防措施以确保长期行动能力的驱动。这些根本性因素正在创造持续的、由人口结构驱动的需求，即对能够缓解老龄化带来的生理影响并支持积极生活方式的产品的需求，这使其区别于短暂的市场趋势。

然而，该行业面临着许多挑战，其中最主要的障碍是严格的法规环境，这限制了健康声明的证实，也阻碍了新产品的进入。儘管有这些监管挑战，消费者对经科学验证的成分的支持依然强劲。例如，负责任营养委员会（Council for Responsible Nutrition）报告称，到2024年，镁（维持骨骼密度所必需的元素）的使用率在膳食补充剂使用者中上升至23%，这凸显了消费者对经科学检验的骨骼健康成分的持续依赖。

市场驱动因素

全球老年人口的快速成长是骨骼和关节保健品市场的主要驱动力。全球人口结构的变化正促使越来越多的人步入与自然老龄化相关的骨骼密度流失年龄段，从而推动了对治疗性和预防性配方产品的稳定需求。这代表着一种持续的结构性转变，而非暂时的激增，确保了维生素D、钙和骨骼强化矿物质的基本摄取量。根据世界经济论坛2025年10月发布的报导《我们是否走在实现健康老化的正确道路上？ 》，预计到2030年，60岁及以上人口将达到14亿，这将为肌肉骨骼健康解决方案创造一个庞大且稳定的消费群。

同时，运动营养补充品在年轻消费者中日益普及，正将市场从老年照护拓展到支持积极生活方式的领域。年轻消费者越来越多地使用胶原蛋白、蛋白质和关节保健补充剂，并非出于治疗目的，而是为了促进运动后的恢復，并在剧烈运动中维护关节健康。这一趋势正在推动以提升运动表现为导向的品类的销售，并促进了预防性补充剂的普及。为了佐证这一商业性潜力，Glanbia 在 2025 年 2 月公布的「2024 财年」全年业绩报告中，旗下 Optimum Nutrition 品牌实现了 7.5% 的营收成长。此外，Thorne HealthTech 报告称，其 2025 年的收入约为 3.94 亿美元，这反映了个人化健康配方所释放的巨大价值。

市场挑战

对健康声明的严格法规环境对全球骨骼和关节保健品市场构成了重大障碍。监管机构严格区分膳食补充剂和药品，要求提供大量的科学证据来证实其功效。这个框架禁止製造商做出诸如「治疗」或「治癒」某些肌肉骨骼疾病（例如骨质疏鬆症或关节炎）的明确声明。因此，企业只能做出更温和的“结构和功能声明”，而这些声明可能无法充分向患有运动障碍或慢性疼痛的消费者传达其产品的治疗潜力。这导致合规成本高昂，并扼杀了创新。

这些监管限制严重限制了该行业利用消费者对天然健康解决方案日益增长的需求的能力。根据责任营养委员会2024年的数据，约80%的膳食补充剂使用者在适当情况下更倾向于选择补充剂而非处方药或非处方药。儘管消费者对非药物干预的需求如此明确，但严格的标籤法规却阻碍了製造商将产品定位为传统药物的直接替代品。因此，企业无法有效传达其产品在维护骨骼和关节健康方面的全部益处，导致商机损失和市场扩张受阻。

市场趋势

软糖、液体和粉末剂型的扩张正在从根本上改变全球骨骼和关节健康补充剂市场，有效缓解了消费者对药片的疲劳感。製造商正逐步抛弃体积大、难以吞嚥的片剂，转而专注于开发偏好的咀嚼片和机能饮料，这些产品在不影响疗效的前提下，融入了葡萄糖胺等复杂的关节支持成分。这种由消费者对便利性需求驱动的转变，促使契约製造生产商大力投资于掩味和质感技术。 2024年5月，Sirio Pharma在一份题为「Sirio Pharma宣布营收快速成长」的新闻稿中宣布，软糖补充剂的销售额同比增长约24.8%，凸显了替代剂型（如软糖、液体和粉末）在传统固态片剂之外的快速发展。

同时，永续采购和优先使用对环境负责的海洋成分正成为品牌吸引具有环保意识的消费者的关键差异化因素。各公司正积极寻求供应链认证，以确保胶原蛋白和Omega-3脂肪酸等关键海洋成分的捕捞方式能够防止过度捕捞并最大程度地减少对生态系统的影响。这一趋势迫使成分供应商采用循环经济实践和严格的可追溯性标准，以证明其对环境的承诺。例如，Aker BioMarine于2025年3月发布的2024年度报告显示，其永续超级宝甲鱼油的销量增长了15%，这证实了该行业对符合伦理规范捕捞的海洋生物活性成分的依赖性日益增强。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球骨骼与关节保健品市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 副产品（维生素、矿物质、胶原蛋白、 Omega-3、葡萄糖胺、其他）
  • 按剂型（胶囊、锭剂、粉末、软胶囊等）
  • 消费群组（婴儿、儿童、成人、孕妇、老年人）划分
  • 依销售管道（实体店（直销、药局、保健食品店、大型超市、超级市场）、电子商务）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美骨骼与关节保健品市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲骨骼与关节保健品市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区骨骼与关节保健品市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东及非洲骨骼及关节保健品市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲骨骼与关节保健品市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球骨骼与关节保健品市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Herbalife International of America, Inc.
• GNC Holdings, LLC
• Nature's Bounty
• BYHEALTH Co., Ltd.
• Amway
• BASF SE
• Bayer AG
• Vitalife Ltd
• Glanbia plc
• NOW Foods

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Bone And Joint Health Supplements Market is projected to expand from USD 3.16 Billion in 2025 to USD 4.45 Billion by 2031, registering a CAGR of 5.87%. These dietary formulations typically contain ingredients such as calcium, vitamin D, glucosamine, chondroitin, and collagen, aimed at preserving skeletal integrity and supporting joint function. The market is primarily propelled by a globally aging population prone to musculoskeletal issues and a growing demographic of younger consumers adopting preventative measures to ensure long-term mobility. These fundamental drivers create a consistent, demographic-based demand for products that counteract the physical impacts of aging and support active lifestyles, distinguishing them from fleeting market trends.

However, the industry faces a significant obstacle in the form of a strict regulatory environment regarding health claim substantiation, which creates barriers for new product entries. Despite these regulatory challenges, consumer commitment to proven ingredients remains strong. For instance, the 'Council for Responsible Nutrition' reported in '2024' that magnesium usage, which is vital for maintaining bone density, increased to 23 percent among supplement users, highlighting the continued reliance on scientifically validated ingredients for skeletal health.

Market Driver

The Rapidly Expanding Global Geriatric Population acts as the primary force driving the bone and joint health supplements market. As demographics shift worldwide, a larger segment of the population is entering age groups associated with natural bone density loss, fueling a steady demand for both therapeutic and preventative formulations. This represents a lasting structural change rather than a temporary surge, ensuring baseline consumption of vitamin D, calcium, and bone-fortifying minerals. According to the World Economic Forum's October 2025 article 'Are we on track when it comes to healthy ageing?', the global population aged 60 and older is expected to reach 1.4 billion by 2030, establishing a vast and permanent consumer base for musculoskeletal health solutions.

Concurrently, the Growing Adoption of Sports Nutrition Among Younger Demographics is broadening the market's reach beyond senior care to include active lifestyle support. Younger consumers are increasingly using collagen, protein, and joint-support supplements to aid recovery and maintain joint health during rigorous physical activities, rather than for treatment purposes. This trend boosts sales in performance-focused categories, confirming a shift toward preventive supplementation. As evidence of this commercial strength, Glanbia plc reported in its '2024 Full Year Results' in February 2025 that its 'Optimum Nutrition' brand achieved 7.5 percent revenue growth. Furthermore, Thorne HealthTech reported 2025 revenues of approximately 394 million USD, reflecting the significant value generated by personalized wellness formulations.

Market Challenge

The stringent regulatory environment regarding health claim substantiation presents a major hurdle for the "Global Bone And Joint Health Supplements Market". Regulatory bodies enforce strict distinctions between dietary supplements and pharmaceutical drugs, necessitating extensive scientific proof to validate efficacy. This framework prohibits manufacturers from making explicit claims about curing or treating specific musculoskeletal conditions such as osteoporosis or arthritis. Consequently, companies are restricted to making softer structure and function claims that may not fully communicate the therapeutic potential of their products to consumers suffering from immobility or chronic pain, leading to high compliance costs and stifled innovation.

These regulatory limitations severely restrict the industry's ability to capitalize on the growing consumer preference for natural health solutions. Data from the 'Council for Responsible Nutrition' in '2024' indicated that nearly 80 percent of dietary supplement users prefer supplements over prescription or over-the-counter medications when appropriate. Despite this clear demand for non-pharmaceutical interventions, strict labeling laws prevent manufacturers from positioning their products as direct alternatives to conventional medicine. As a result, companies cannot effectively convey the full benefits of their bone and joint health formulations, resulting in missed revenue opportunities and hampered market expansion.

Market Trends

The Diversification into Gummy, Liquid, and Powder Delivery Formats is fundamentally transforming the Global Bone And Joint Health Supplements Market by addressing consumer pill fatigue. Manufacturers are shifting away from large, difficult-to-swallow tablets to create palatable chewables and functional beverages that incorporate complex joint-support ingredients like glucosamine without sacrificing efficacy. This transition is driven by a demand for convenience, compelling contract manufacturers to invest heavily in flavor masking and texture technologies. In May 2024, Sirio Pharma announced in its 'Sirio Pharma announces surge in revenue' press release that its gummy supplement sales grew by approximately 24.8 percent year-over-year, highlighting the rapid expansion of alternative delivery systems over traditional solid forms.

Simultaneously, the Prioritization of Sustainably Sourced and Eco-Friendly Marine Ingredients is becoming a critical differentiator for brands aiming to align with environmentally conscious consumers. Companies are aggressively certifying their supply chains to ensure that key marine inputs, such as collagen and omega-3 fatty acids, are harvested using methods that prevent overfishing and minimize ecosystem impact. This trend forces ingredient suppliers to adopt circular economy practices and rigorous traceability standards to validate their ecological credentials. Illustrating this shift, Aker BioMarine's 'Annual Report 2024', released in March 2025, showed a 15 percent increase in sales of its sustainable Superba krill oil, confirming the industry's growing reliance on ethically harvested marine bioactives.

Key Market Players

• Herbalife International of America, Inc.
• GNC Holdings, LLC
• Nature's Bounty
• BYHEALTH Co., Ltd.
• Amway
• BASF SE
• Bayer AG
• Vitalife Ltd
• Glanbia plc
• NOW Foods

Report Scope

In this report, the Global Bone And Joint Health Supplements Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bone And Joint Health Supplements Market, By Product

• Vitamins
• Mineral
• Collagen
• Omega-3
• Glucosamine
• Others

Bone And Joint Health Supplements Market, By Formulation

• Capsules
• Tablets
• Powders
• Softgels
• Others

Bone And Joint Health Supplements Market, By Consumer Group

• Infants
• Children
• Adults
• Pregnant Women
• Geriatric Population

Bone And Joint Health Supplements Market, By Sales Channel

• Bricks And Mortar (Direct Selling, Chemists/Pharmacies, Health Food Shops, Hyper Markets, Super Markets)
• E-Commerce

Bone And Joint Health Supplements Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bone And Joint Health Supplements Market.

Available Customizations:

Global Bone And Joint Health Supplements Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bone And Joint Health Supplements Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Vitamins, Mineral, Collagen, Omega-3, Glucosamine, Others)
  • 5.2.2. By Formulation (Capsules, Tablets, Powders, Softgels, Others)
  • 5.2.3. By Consumer Group (Infants, Children, Adults, Pregnant Women, Geriatric Population)
  • 5.2.4. By Sales Channel (Bricks And Mortar (Direct Selling, Chemists/Pharmacies, Health Food Shops, Hyper Markets, Super Markets), E-Commerce)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Bone And Joint Health Supplements Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Formulation
  • 6.2.3. By Consumer Group
  • 6.2.4. By Sales Channel
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Bone And Joint Health Supplements Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Formulation
      • 6.3.1.2.3. By Consumer Group
      • 6.3.1.2.4. By Sales Channel
  • 6.3.2. Canada Bone And Joint Health Supplements Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Formulation
      • 6.3.2.2.3. By Consumer Group
      • 6.3.2.2.4. By Sales Channel
  • 6.3.3. Mexico Bone And Joint Health Supplements Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Formulation
      • 6.3.3.2.3. By Consumer Group
      • 6.3.3.2.4. By Sales Channel

7. Europe Bone And Joint Health Supplements Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Formulation
  • 7.2.3. By Consumer Group
  • 7.2.4. By Sales Channel
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Bone And Joint Health Supplements Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Formulation
      • 7.3.1.2.3. By Consumer Group
      • 7.3.1.2.4. By Sales Channel
  • 7.3.2. France Bone And Joint Health Supplements Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Formulation
      • 7.3.2.2.3. By Consumer Group
      • 7.3.2.2.4. By Sales Channel
  • 7.3.3. United Kingdom Bone And Joint Health Supplements Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Formulation
      • 7.3.3.2.3. By Consumer Group
      • 7.3.3.2.4. By Sales Channel
  • 7.3.4. Italy Bone And Joint Health Supplements Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Formulation
      • 7.3.4.2.3. By Consumer Group
      • 7.3.4.2.4. By Sales Channel
  • 7.3.5. Spain Bone And Joint Health Supplements Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Formulation
      • 7.3.5.2.3. By Consumer Group
      • 7.3.5.2.4. By Sales Channel

8. Asia Pacific Bone And Joint Health Supplements Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Formulation
  • 8.2.3. By Consumer Group
  • 8.2.4. By Sales Channel
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Bone And Joint Health Supplements Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Formulation
      • 8.3.1.2.3. By Consumer Group
      • 8.3.1.2.4. By Sales Channel
  • 8.3.2. India Bone And Joint Health Supplements Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Formulation
      • 8.3.2.2.3. By Consumer Group
      • 8.3.2.2.4. By Sales Channel
  • 8.3.3. Japan Bone And Joint Health Supplements Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Formulation
      • 8.3.3.2.3. By Consumer Group
      • 8.3.3.2.4. By Sales Channel
  • 8.3.4. South Korea Bone And Joint Health Supplements Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Formulation
      • 8.3.4.2.3. By Consumer Group
      • 8.3.4.2.4. By Sales Channel
  • 8.3.5. Australia Bone And Joint Health Supplements Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Formulation
      • 8.3.5.2.3. By Consumer Group
      • 8.3.5.2.4. By Sales Channel

9. Middle East & Africa Bone And Joint Health Supplements Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Formulation
  • 9.2.3. By Consumer Group
  • 9.2.4. By Sales Channel
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Bone And Joint Health Supplements Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Formulation
      • 9.3.1.2.3. By Consumer Group
      • 9.3.1.2.4. By Sales Channel
  • 9.3.2. UAE Bone And Joint Health Supplements Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Formulation
      • 9.3.2.2.3. By Consumer Group
      • 9.3.2.2.4. By Sales Channel
  • 9.3.3. South Africa Bone And Joint Health Supplements Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Formulation
      • 9.3.3.2.3. By Consumer Group
      • 9.3.3.2.4. By Sales Channel

10. South America Bone And Joint Health Supplements Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Formulation
  • 10.2.3. By Consumer Group
  • 10.2.4. By Sales Channel
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Bone And Joint Health Supplements Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Formulation
      • 10.3.1.2.3. By Consumer Group
      • 10.3.1.2.4. By Sales Channel
  • 10.3.2. Colombia Bone And Joint Health Supplements Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Formulation
      • 10.3.2.2.3. By Consumer Group
      • 10.3.2.2.4. By Sales Channel
  • 10.3.3. Argentina Bone And Joint Health Supplements Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Formulation
      • 10.3.3.2.3. By Consumer Group
      • 10.3.3.2.4. By Sales Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Bone And Joint Health Supplements Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Herbalife International of America, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. GNC Holdings, LLC
• 15.3. Nature's Bounty
• 15.4. BYHEALTH Co., Ltd.
• 15.5. Amway
• 15.6. BASF SE
• 15.7. Bayer AG
• 15.8. Vitalife Ltd
• 15.9. Glanbia plc
• 15.10. NOW Foods

16. Strategic Recommendations

17. About Us & Disclaimer